Narrow Results By
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
https://policybase.cma.ca/link/policy11519
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
https://policybase.cma.ca/link/policy10437
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)
https://policybase.cma.ca/link/policy11599
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
https://policybase.cma.ca/link/policy10382
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
https://policybase.cma.ca/link/policy10631
Complementary and alternative medicine (update 2015)
https://policybase.cma.ca/link/policy11529
- Date
- 2015-05-30
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
- Policy Type
- Policy document
- Date
- 2015-05-30
- Replaces
- Complementary and alternative medicine (Update 2008)
Documents
Harms associated with opioids and other psychoactive prescription drugs
https://policybase.cma.ca/link/policy11535
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
https://policybase.cma.ca/link/policy1950
- Last Reviewed
- 2012-03-03
- Date
- 2005-04-20
- Topics
- Population health, health equity, public health
- Pharmaceuticals, prescribing, cannabis, drugs
- Policy Type
- Parliamentary submission
- Last Reviewed
- 2012-03-03
- Date
- 2005-04-20
- Topics
- Population health, health equity, public health
- Pharmaceuticals, prescribing, cannabis, drugs